Patient-derived complex organoids are a critical tool to understand and explore pediatric malignant brain tumors

Pediatric malignant brain tumors (PMBTs) remain among the most common and challenging cancers in children and adolescents, with current therapies often failing to deliver satisfactory outcomes. A major obstacle is their intrinsic and extrinsic resistance mechanisms, underscoring the urgent need for innovative therapeutic strategies and accurate preclinical modeling. Recent advances in organoid-based technologies offer promising tools to mimic PMBTs more faithfully in vitro. These three-dimensional (3D) models can replicate key features of the tumor and its brain-like microenvironment, providing valuable platforms for studying resistant cancer cells and testing novel treatment approaches. This review discusses the relevance of cultured 3D systems, organoids and tumoroids, in pediatric neuro-oncology, emphasizing their role in precision medicine. These models have become essential for dissecting the complex biology and dynamic biological processes of all PMBTs, while bridging clinical challenges with experimental discoveries, ultimately enabling more effective and personalized treatments for young patients.

Authors

Institutions

Publication Details

Journal
Cancer and Metastasis Reviews
Published
2026-03-03
DOI
https://doi.org/10.1007/s10555-026-10316-3
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-derived complex organoids are a critical tool to understand and explore pediatric malignant brain tumors

Antony Joud, Sophie Martin, Érika Cosset, Marie Duhamel et al.
Cancer and Metastasis Reviews
Glioma Diagnosis and Treatment
article

Patient-derived complex organoids are a critical tool to understand and explore pediatric malignant brain tumors

Antony Joud, Sophie Martin, Érika Cosset, Marie Duhamel, Marlène Deschuyter, Chloé Bernhard, Vincent Flacher, Audrey A. Vincent, Clémence Hubsch, Samuel Meignan, Chinar Salmanli, Céline Frochot, Sandra Raimbault, Michel Salzet, Georges Noel, Mélodie Anne Karnoub, Natacha Entz-Werlé, Hélène Sudour-Bonnange, Antonella Raffo-Romero, Alessandro Furlan, Sophie Pinel, Andres Coca, Cedric Boura
article en

Abstract

Pediatric malignant brain tumors (PMBTs) remain among the most common and challenging cancers in children and adolescents, with current therapies often failing to deliver satisfactory outcomes. A major obstacle is their intrinsic and extrinsic resistance mechanisms, underscoring the urgent need for innovative therapeutic strategies and accurate preclinical modeling. Recent advances in organoid-based technologies offer promising tools to mimic PMBTs more faithfully in vitro. These three-dimensional (3D) models can replicate key features of the tumor and its brain-like microenvironment, providing valuable platforms for studying resistant cancer cells and testing novel treatment approaches. This review discusses the relevance of cultured 3D systems, organoids and tumoroids, in pediatric neuro-oncology, emphasizing their role in precision medicine. These models have become essential for dissecting the complex biology and dynamic biological processes of all PMBTs, while bridging clinical challenges with experimental discoveries, ultimately enabling more effective and personalized treatments for young patients.

Cancer and Metastasis ReviewsVol. 45(1)
Centre National de la Recherche Scientifique (FR), Inserm (FR), Université de Lille (FR), Centre Hospitalier Universitaire de Lille (FR), Lille’s Cardiology Hospital (FR), Laboratoire de Biophotonique et Pharmacologie (FR), BC Platforms (Finland) (FI), Centre Hospitalier Régional et Universitaire de Nancy (FR), Levi Strauss (United States) (US), Délégation Centre-Est (FR), Centre de Recherche en Automatique de Nancy (FR), Centre de Recherche en Cancérologie de Lyon (FR), Centre Oscar Lambret (FR), Immunologie, Immunopathologie et Chimie Thérapeutique (FR), Institut de Biologie Moléculaire et Cellulaire (FR), Institut Polytechnique de Bordeaux (FR), Hôpital Civil, Strasbourg (FR), Université de Strasbourg (FR)
Institut National Du Cancer
Good health and well-being
Openalex Percentile: Top 37%
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.